Cite
HARVARD Citation
Merrill, J. et al. (n.d.). SAT0219 Efficacy and safety of atacicept in patients with high disease activity in a 24-week, randomized, placebo-controlled, phase iib study (ADDRESS II). Annals of the rheumatic diseases. p. 856. [Online].